Dubai [UAE], Burjeel Holdings today announced the launch of the Burjeel Institute for Global Health in the United States.
The launch event was attended by Dr Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade, who discussed how the UAE, in collaboration with international partners, is leading efforts to use research and education to improve health outcomes global.
The inauguration of the institute was marked by a series of high-level discussions focused on cancer care and technological innovations, featuring Dr. Ashwin Vasan, commissioner of the New York City Department of Health and Mental Hygiene, and a diverse group of global experts.
"The UAE is committed to taking healthcare to the next level. Our focus includes facilitating research and development partnerships, bringing best practices to UAE hospitals and investing in technology to enhance our capabilities. Fighting cancer It is one of the most critical challenges we face and we are determined to find solutions that can save lives, provide stability for families and provide hope to the many children fighting this cruel disease. Success requires a holistic approach and, in particular, the collaboration of the private sector, academia, regulators and NGOs," he said.
Commenting on the inauguration of the institute, Dr Al Zeyoudi said he hoped the Burjeel Institute for Global Health would be a hub for research, treatment and development of innovative cancer drugs and foster partnerships by sharing experiences, ensuring best practices and improve knowledge and skills.
By establishing the institute, the UAE-based healthcare group aims to expand its reach of talent and academic excellence, facilitating the recruitment of top-notch researchers, scientists and medical professionals. This initiative is set to significantly boost Burjeel's clinical and research strengths, reinforcing its position as a leading global healthcare provider.
Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, said the opening of the Burjeel Institute for Global Health in New York is an important milestone in opening doors to meaningful collaborations with leading healthcare institutions and companies. "Our goal is to drive advances in medical treatment and technology and ultimately improve health outcomes around the world."
Through its New York office, Burjeel Holdings aims to expand its position as a key player in global healthcare through innovative collaborations that will pave the way to improve health outcomes on an international scale.
The launch event was attended by Dr Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade, who discussed how the UAE, in collaboration with international partners, is leading efforts to use research and education to improve health outcomes global.
The inauguration of the institute was marked by a series of high-level discussions focused on cancer care and technological innovations, featuring Dr. Ashwin Vasan, commissioner of the New York City Department of Health and Mental Hygiene, and a diverse group of global experts.
"The UAE is committed to taking healthcare to the next level. Our focus includes facilitating research and development partnerships, bringing best practices to UAE hospitals and investing in technology to enhance our capabilities. Fighting cancer It is one of the most critical challenges we face and we are determined to find solutions that can save lives, provide stability for families and provide hope to the many children fighting this cruel disease. Success requires a holistic approach and, in particular, the collaboration of the private sector, academia, regulators and NGOs," he said.
Commenting on the inauguration of the institute, Dr Al Zeyoudi said he hoped the Burjeel Institute for Global Health would be a hub for research, treatment and development of innovative cancer drugs and foster partnerships by sharing experiences, ensuring best practices and improve knowledge and skills.
By establishing the institute, the UAE-based healthcare group aims to expand its reach of talent and academic excellence, facilitating the recruitment of top-notch researchers, scientists and medical professionals. This initiative is set to significantly boost Burjeel's clinical and research strengths, reinforcing its position as a leading global healthcare provider.
Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, said the opening of the Burjeel Institute for Global Health in New York is an important milestone in opening doors to meaningful collaborations with leading healthcare institutions and companies. "Our goal is to drive advances in medical treatment and technology and ultimately improve health outcomes around the world."
Through its New York office, Burjeel Holdings aims to expand its position as a key player in global healthcare through innovative collaborations that will pave the way to improve health outcomes on an international scale.
